Qiagen NV QIA-DE:XETRA

*Data is delayed | EUR
Last | 5:35 PM CEST
42.38quote price arrow down-0.66 (-1.53%)
Volume
297,683
52 week range
36.00 - 46.95

...

Loading . . .
  • Open42.81
  • Day High43.02
  • Day Low42.35
  • Prev Close43.04
  • 52 Week High46.95
  • 52 Week High Date10/13/20
  • 52 Week Low36.00
  • 52 Week Low Date11/09/20

Key Stats

  • Market Cap12,021.14M
  • Shares Out227.75M
  • 10 Day Average Volume383,167.4
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-0.16

KEY STATS

  • Open42.81
  • Day High43.02
  • Day Low42.35
  • Prev Close43.04
  • 52 Week High46.95
  • 52 Week High Date10/13/20
  • 52 Week Low36.00
  • 52 Week Low Date11/09/20
  • Market Cap12,021.14M
  • Shares Out227.75M
  • 10 Day Average Volume383,167.4
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-0.16

RATIOS/PROFITABILITY

  • EPS (TTM)1.25
  • P/E (TTM)33.90
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date01/25/2017
  • Div Amount1.08
  • Split Date-
  • Split Factor-

Profile

MORE
QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay...
Thierry Bernard
Chief Executive Officer
Roland Sackers
Chief Financial Officer
Address
Hulsterweg 82
Venlo
5912 PL
Netherlands